Clumping factors A (ClfA) and B (ClfB) are Staphylococcus aureus virulence proteins that are displayed on the cell surface of the organism and have potential as vaccine antigens for the prevention of S. aureus disease. Here we evaluate the phylogeny of S. aureus in the context of antigenic variation of these two surface proteins. ClfA and ClfB gene sequences, along with epidemiological markers (MLST, spa and capsule genotype) were obtained for 224 S. aureus isolates including both historical strains and a collection representative of current MRSA isolates from the United States. Variation within ClfA and ClfB was consistent with the established population biology of S. aureus, namely, that S. aureus strains belong to a relatively small number of clonal lineages, with evolution proceeding mainly by mutation and with little to no recombination between clades. Thus most variation in ClfA and ClfB occurs between but not within lineages, and particular groups of ClfA and ClfB variants are closely linked. This has important implications for vaccine development and assessment as it suggests that a relatively small survey of strains will be representative of the total population variation, whereas for species that evolve mainly by recombination, such as Neisseria meningitidis, analysis of a much larger number of strains is needed to accomplish the same purpose. Our study also revealed evidence for the de-evolution of ClfB and therefore its reduced suitability as a target for vaccine development compared to ClfA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4161/hv.7.0.14562 | DOI Listing |
J Appl Microbiol
November 2024
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, Kukatpally Industrial Area, Hyderabad- 500037, Telangana, India.
Aims: Staphylococcus aureus, a high-priority pathogen proclaimed to cause infections ranging from mild to life-threatening, presents significant challenges in treatment. New therapies can be developed quicker using open drug discovery platforms offering a distinct approach to expedite the development of innovative antibacterial and anti-biofilm therapeutics. This study set out to address these issues by finding new uses for current medications to find compounds that are effective against S.
View Article and Find Full Text PDFFront Cell Infect Microbiol
October 2024
College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Introduction: is a highly resistant pathogen. It has multiple virulence factors, which makes it one of the most pathogenic bacteria for humankind. The vast increase in antibiotic resistance in these bacteria is a warning of existing healthcare policies.
View Article and Find Full Text PDFJ Appl Microbiol
August 2024
Department of Pathobiology, Faculty of Veterinary Science, Bu-Ali Sina University, Hamadan 6517658978, Iran.
Aims: This study aimed to investigate the effect of Oliveria decumbens essential oil (Od-EO) on the phenotypic properties and gene expression of Staphylococcus aureus biofilm on commonly used food contact surfaces.
Methods And Results: The minimum inhibitory concentration and minimum bactericidal concentration of Od-EO on S. aureus ATCC25923 were determined to be 0.
Sci Rep
June 2024
Department of Biosciences, COMSATS University Islamabad, Park Road, Tarlai Kalan, Islamabad, Pakistan.
Mastitis is considered one of the most widespread infectious disease of cattle and buffaloes, affecting dairy herds. The current study aimed to characterize the Staphylococcus aureus isolates recovered from subclinical mastitis animals in Pothohar region of the country. A total of 278 milk samples from 17 different dairy farms around two districts of the Pothohar region, Islamabad and Rawalpindi, were collected and screened for sub clinical mastitis using California Mastitis Test.
View Article and Find Full Text PDFFront Cell Infect Microbiol
April 2024
Division of Thoracic and Cardiovascular Surgery, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Introduction: , is a pathogen commonly encountered in both community and hospital settings. Patients receiving hemodialysis treatment face an elevated risk of vascular access infections (VAIs) particularly , infection. This heightened risk is attributed to the characteristics of , , enabling it to adhere to suitable surfaces and form biofilms, thereby rendering it resistant to external interventions and complicating treatment efforts.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!